Birdwatch Note
2021-08-26 00:02:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Since Ivermectin is not authorized for use in treating COVID-19 in the U.S., CVS Caremark corporation has the right to not sell or limit the quantities of "off-label" drugs or treatment such as this one. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 https://www.drugtopics.com/view/cvs-caremark-sets-limits-label-treatments-covid-19
Written by 9795BF8962792425EFA8D2F4F92685B4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1429588609007382532
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1430682114580795398
- noteId - 1430682114580795398
- participantId - 9795BF8962792425EFA8D2F4F92685B4
- noteAuthorParticipantId -
- createdAtMillis - 1629936171566
- tweetId - 1429588609007382532
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Since Ivermectin is not authorized for use in treating COVID-19 in the U.S., CVS Caremark corporation has the right to not sell or limit the quantities of "off-label" drugs or treatment such as this one. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 https://www.drugtopics.com/view/cvs-caremark-sets-limits-label-treatments-covid-19
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2021-08-26 00:02:51 UTC (1629936171566) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
CURRENTLY_RATED_HELPFUL | 1969-12-31 23:59:59 UTC (-1) |
47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | ||
2021-08-26 00:02:51 UTC (1629936171566) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
CURRENTLY_RATED_HELPFUL | 1969-12-31 23:59:59 UTC (-1) |
9795BF8962792425EFA8D2F4F92685B4 |
Note Ratings
rated at | rated by | |
2021-08-25 22:34:13 -0500 | 26C417A4A7E7B9DAA77E59278C0A05E893712F5C6074F6266758A56DE7D5B088 | Rating Details |
2021-08-28 14:18:36 -0500 | 392C4B011A46BA2024F5ABF61755F877859A133C308AA637FA006C597202EE79 | Rating Details |
2021-08-25 21:32:34 -0500 | 8DC15A6C312E139906C124D90F6ACDBA007986DD0095983D5E35866D99F161A2 | Rating Details |
2021-08-25 19:12:50 -0500 | 99C9E6DE2BA16D23C320C1879BDDEE7DEA7686BE2B3B0C6B5AC5DD524EDA5D44 | Rating Details |
2021-08-27 08:52:03 -0500 | AD3865056404D64BF9C019FE4792FFB6CFDEEAB67EB311BA135F15D0357BAEC6 | Rating Details |
2021-08-26 11:57:51 -0500 | CB52F3F8AE76F98D5D4E0B13341EF5A8840FFDA1EA8B21B0AC08A25458C8C4EE | Rating Details |
2021-08-25 19:11:35 -0500 | CF92BDCE99BE54DA1B4908EF1CAE8AD3288902E489B6A71E370B824AAA2C3C95 | Rating Details |
2021-08-26 11:28:18 -0500 | E874D0C10B03C31CDBF909EB345ADF2FAB4EB3F1B7E668F3EDCDEF9D6B567E12 | Rating Details |
2021-08-25 22:34:13 -0500 | Rating Details | |
2021-08-25 19:11:35 -0500 | Rating Details | |
2021-08-28 14:18:36 -0500 | Rating Details | |
2021-08-26 11:57:51 -0500 | Rating Details | |
2021-08-27 08:52:03 -0500 | Rating Details | |
2021-08-26 11:28:18 -0500 | Rating Details | |
2021-08-25 21:32:34 -0500 | Rating Details | |
2021-08-25 19:12:50 -0500 | Rating Details |